Vižlin, A.; Andersch Björkman, Y.; Kumar, Y.; Göthe, M.; Gillstedt, M.; Osmančević, A.
No Evidence of Gut Microbiota Alteration in Psoriasis Patients Switching to Brodalumab after Loss of TNFα Inhibition Effect. Int. J. Mol. Sci. 2024, 25, 7745.
https://doi.org/10.3390/ijms25147745
AMA Style
Vižlin A, Andersch Björkman Y, Kumar Y, Göthe M, Gillstedt M, Osmančević A.
No Evidence of Gut Microbiota Alteration in Psoriasis Patients Switching to Brodalumab after Loss of TNFα Inhibition Effect. International Journal of Molecular Sciences. 2024; 25(14):7745.
https://doi.org/10.3390/ijms25147745
Chicago/Turabian Style
Vižlin, Admir, Ylva Andersch Björkman, Yadhu Kumar, Maria Göthe, Martin Gillstedt, and Amra Osmančević.
2024. "No Evidence of Gut Microbiota Alteration in Psoriasis Patients Switching to Brodalumab after Loss of TNFα Inhibition Effect" International Journal of Molecular Sciences 25, no. 14: 7745.
https://doi.org/10.3390/ijms25147745
APA Style
Vižlin, A., Andersch Björkman, Y., Kumar, Y., Göthe, M., Gillstedt, M., & Osmančević, A.
(2024). No Evidence of Gut Microbiota Alteration in Psoriasis Patients Switching to Brodalumab after Loss of TNFα Inhibition Effect. International Journal of Molecular Sciences, 25(14), 7745.
https://doi.org/10.3390/ijms25147745
